Silvia Monticone1, Sascha Bandulik, Julia Stindl, Mihail Zilbermint, Ivan Dedov, Paolo Mulatero, Michael Allgaeuer, Chyi-Chia Richard Lee, Constantine A Stratakis, Tracy A Williams, Anatoly Tiulpakov. 1. Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences (S.M., P.M., T.A.W.), University of Torino, Torino 10124 Italy; Medical Cell Biology (S.B., J.S.), University of Regensburg, 93053 Regensburg, Germany; Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development (M.Z., C.A.S.), and Laboratory of Pathology (M.A., C.-C.R.L.), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892; and Department of Inherited Endocrine Disorders (I.D., A.T.), Endocrinology Research Centre, Moscow 117036, Russia.
Abstract
CONTEXT: Familial hyperaldosteronism type III (FH-III) is a rare and clinically heterogeneous condition, that can display mild as well as severe phenotypes. Point mutations in the KCNJ5 gene, affecting the ion selectivity of the inward rectifier K(+) channel 4 (Kir3.4), underlie the molecular basis of FH-III. OBJECTIVE: The objective of the study was to investigate the effects of a de novo germline KCNJ5 mutation. PATIENTS AND METHODS: We describe the case of a girl who came to medical attention at the age of 2 years because of polydipsia, polyuria, and failure to thrive. The patient, affected by hypertension and hypokalemia, was diagnosed with primary aldosteronism on the basis of extremely high aldosterone levels and suppressed plasma renin activity. Genomic DNA was isolated and KCNJ5 sequenced. Human adrenocortical cells were used as an in vitro model for the functional characterization of the mutant channel. RESULTS: KCNJ5 sequencing in the index case and her parents revealed a de novo p.Glu145Gln germline mutation. The substitution resulted in Na(+)-dependent depolarization of adrenal cells and increased intracellular calcium concentration, which activated the transcription of NR4A2 and, in turn, CYP11B2. Pharmacological studies revealed that the mutant channel was insensitive to tertiapin-Q and calcium-channel blocker verapamil. CONCLUSIONS: Herein we report the identification of a novel KCNJ5 germline mutation responsible for severe hyperaldosteronism that presented in infancy with symptoms of diabetes insipidus. The findings of this study further elucidate the etiology of FH-III and expand our knowledge of this rare condition.
CONTEXT: Familial hyperaldosteronism type III (FH-III) is a rare and clinically heterogeneous condition, that can display mild as well as severe phenotypes. Point mutations in the KCNJ5 gene, affecting the ion selectivity of the inward rectifier K(+) channel 4 (Kir3.4), underlie the molecular basis of FH-III. OBJECTIVE: The objective of the study was to investigate the effects of a de novo germline KCNJ5 mutation. PATIENTS AND METHODS: We describe the case of a girl who came to medical attention at the age of 2 years because of polydipsia, polyuria, and failure to thrive. The patient, affected by hypertension and hypokalemia, was diagnosed with primary aldosteronism on the basis of extremely high aldosterone levels and suppressed plasma renin activity. Genomic DNA was isolated and KCNJ5 sequenced. Humanadrenocortical cells were used as an in vitro model for the functional characterization of the mutant channel. RESULTS:KCNJ5 sequencing in the index case and her parents revealed a de novo p.Glu145Gln germline mutation. The substitution resulted in Na(+)-dependent depolarization of adrenal cells and increased intracellular calcium concentration, which activated the transcription of NR4A2 and, in turn, CYP11B2. Pharmacological studies revealed that the mutant channel was insensitive to tertiapin-Q and calcium-channel blocker verapamil. CONCLUSIONS: Herein we report the identification of a novel KCNJ5 germline mutation responsible for severe hyperaldosteronism that presented in infancy with symptoms of diabetes insipidus. The findings of this study further elucidate the etiology of FH-III and expand our knowledge of this rare condition.
Authors: D A Doyle; J Morais Cabral; R A Pfuetzner; A Kuo; J M Gulbis; S L Cohen; B T Chait; R MacKinnon Journal: Science Date: 1998-04-03 Impact factor: 47.728
Authors: Katherine M Dibb; Thierry Rose; Samy Y Makary; Thomas W Claydon; Decha Enkvetchakul; Robert Leach; Colin G Nichols; Mark R Boyett Journal: J Biol Chem Date: 2003-09-22 Impact factor: 5.157
Authors: David S Geller; Junhui Zhang; Max V Wisgerhof; Cedric Shackleton; Michael Kashgarian; Richard P Lifton Journal: J Clin Endocrinol Metab Date: 2008-05-27 Impact factor: 5.958
Authors: Natividad Pons Fernández; Francisca Moreno; Julia Morata; Ana Moriano; Sara León; Carmen De Mingo; Ángel Zuñiga; Fernando Calvo Journal: Rev Endocr Metab Disord Date: 2019-03 Impact factor: 6.514
Authors: S Monticone; M Tetti; J Burrello; F Buffolo; R De Giovanni; F Veglio; T A Williams; P Mulatero Journal: J Hum Hypertens Date: 2017-04-27 Impact factor: 3.012
Authors: Mihail Zilbermint; Paraskevi Xekouki; Fabio R Faucz; Annabel Berthon; Alexandra Gkourogianni; Marie Helene Schernthaner-Reiter; Maria Batsis; Ninet Sinaii; Martha M Quezado; Maria Merino; Aaron Hodes; Smita B Abraham; Rossella Libé; Guillaume Assié; Stéphanie Espiard; Ludivine Drougat; Bruno Ragazzon; Adam Davis; Samson Y Gebreab; Ryan Neff; Electron Kebebew; Jérôme Bertherat; Maya B Lodish; Constantine A Stratakis Journal: J Clin Endocrinol Metab Date: 2015-03-30 Impact factor: 5.958
Authors: Christina Tatsi; Andrea G Maria; Cole Malloy; Lin Lin; Edra London; Nick Settas; Chelsi Flippo; Meg Keil; Fady Hannah-Shmouni; Dax A Hoffman; Constantine A Stratakis Journal: J Clin Endocrinol Metab Date: 2021-05-13 Impact factor: 5.958